Core Viewpoint - Spring Medical experienced a decline of 3.93% on October 9, with a trading volume of 93.15 million yuan and a total market capitalization of 9.179 billion yuan [1] Company Overview - Spring Medical is a leading domestic orthopedic medical device manufacturer, focusing on the research, production, and sales of implantable orthopedic medical devices, including oral metal and invisible orthodontics, as well as oral implants and restorations [2][5] - The company is located in Tongzhou District, Beijing, and was established on February 12, 1998, with its listing date on December 30, 2021 [7][8] - Main products include joint prosthetics covering hip, knee, shoulder, and elbow joints, and a full range of spinal implant products [5][8] Business Development - The company is currently in the design and inspection phase for a customized porous tantalum dental implant product [2] - Spring Medical has introduced various types of 3D printing equipment, including EBM and MJF, to advance the development of customized prosthetic products [2][3] - The company has been recognized as a "specialized and innovative" small giant enterprise, indicating strong innovation capabilities and high market share [3] Financial Performance - For the first half of 2025, Spring Medical achieved operating revenue of 488 million yuan, a year-on-year increase of 28.27%, and a net profit attributable to shareholders of 114 million yuan, up 44.85% year-on-year [8] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan in the last three years [8] Shareholder Structure - As of June 30, 2025, the top ten circulating shareholders include Ping An Low Carbon Economy Mixed A and Southern Medical Health Flexible Allocation Mixed A, with notable changes in holdings [9]
春立医疗跌3.93%,成交额9315.46万元,近5日主力净流入-102.44万